ARS Pharmaceuticals, Inc. (SPRY)
Market: NASD |
Currency: USD
Address: 11682 El Camino Real
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
📈 ARS Pharmaceuticals, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$31.60
-
Upside/Downside from Analyst Target:
98.62%
-
Broker Call:
12
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
50-100%
-
Revenue Growth Range (1Y):
>500%
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for ARS Pharmaceuticals, Inc.
| Date | Reported EPS |
|---|
| 2026-05-12 (estimated upcoming) | - |
| 2026-03-18 (estimated upcoming) | - |
| 2025-11-11 (estimated upcoming) | - |
| 2025-11-10 (estimated upcoming) | - |
| 2025-08-04 (estimated upcoming) | - |
| 2025-08-03 (estimated upcoming) | - |
| 2025-05-14 | - |
| 2025-05-14 | -0.35 |
| 2025-05-06 | - |
| 2025-03-20 | 0.49 |
| 2025-03-18 | - |
| 2025-01-13 | - |
| 2024-11-13 | -0.2 |
| 2024-08-06 | -0.13 |
| 2024-08-05 | -0.13 |
| 2024-05-09 | -0.11 |
| 2024-05-08 | -0.11 |
| 2024-03-21 | -0.07 |
| 2024-03-20 | -0.07 |
| 2023-11-09 | -0.16 |
| 2023-11-08 | -0.16 |
| 2023-08-10 | -0.18 |
| 2023-08-09 | -0.18 |
| 2023-05-15 | -0.16 |
| 2023-05-14 | -0.16 |
| 2023-03-23 | 0.77 |
| 2023-03-22 | 0.77 |
| 2022-11-02 | -0.5 |
| 2022-11-01 | -0.5 |
| 2022-08-11 | -0.55 |
| 2022-08-10 | -0.55 |
| 2022-05-12 | -0.7 |
| 2022-05-11 | -0.7 |
| 2022-03-31 | -0.67 |
| 2022-03-30 | -0.67 |
| 2021-11-10 | -0.65 |
| 2021-11-09 | -0.65 |
| 2021-08-12 | -0.7 |
| 2021-08-11 | -0.7 |
| 2021-05-13 | -0.54 |
| 2021-05-12 | -0.54 |
| 2021-03-29 | -1.37 |
| 2021-03-28 | -1.37 |
| 2020-11-10 | - |
| 2020-11-09 | - |
📰 Related News & Research
No related articles found for "ars pharmaceuticals".
